Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05654441 · ClinicalTrials.gov registry record · Phase 4
Body and Social Behavior
A Phase 4 study, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- Phase 4
- Development phase
- 104
- Enrollment target
NCT05654441 is a Phase 4 study that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 104 participants.
The verdict
NCT05654441, a Phase 4 study, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 104 participants
- Enrollment target
Study Summary
This randomized, double-blind, placebo-controlled study of the influenza vaccine will shed important light on how the immune system responds to different positive and negative social experiences. Building on the nuanced animal literature showing that, while animals exposed to an inflammatory challenge show reductions in social exploration consistent with the sickness behavior of social withdrawal, they actually show increases in social engagement behavior during interactions with a cage mate or pair-bonded animal. The present study will examine if a mild inflammatory challenge (receipt of the influenza vaccine) leads to change in actual social behavior in interactions, specifically toward a stranger and separately, toward a close friend. This study will also build on foundational animal research showing that an inflammatory challenge leads to social defeat behaviors in animals.
Interventions
- BIOLOGICAL Placebo
- BIOLOGICAL Influenza vaccine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 104 participants |
| Start Date | 2022-10-17 |
| Est. Completion | 2023-12-15 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05654441
The ClinicalTrials.gov registry entry for NCT05654441 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 104 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT05654441 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05654441 about?
NCT05654441 is a clinical study titled "Body and Social Behavior". This randomized, double-blind, placebo-controlled study of the influenza vaccine will shed important light on how the immune system responds to different positive and negative social experiences. Building on the nuanced animal literature showing that, while animals exposed to an inflammatory challen...
What is the current status of trial NCT05654441?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 104 participants. The study started on 2022-10-17. Estimated completion is 2023-12-15.
What interventions are being tested in trial NCT05654441?
The interventions under investigation include: Placebo (BIOLOGICAL), Influenza vaccine (BIOLOGICAL).
Who is sponsoring clinical trial NCT05654441?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.